These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

377 related items for PubMed ID: 20482298

  • 1. Non-invasive fetal RHD genotyping in the first trimester of pregnancy.
    Cardo L, García BP, Alvarez FV.
    Clin Chem Lab Med; 2010 Aug; 48(8):1121-6. PubMed ID: 20482298
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Diagnostic accuracy of fetal rhesus D genotyping using cell-free fetal DNA during the first trimester of pregnancy.
    Vivanti A, Benachi A, Huchet FX, Ville Y, Cohen H, Costa JM.
    Am J Obstet Gynecol; 2016 Nov; 215(5):606.e1-606.e5. PubMed ID: 27393271
    [Abstract] [Full Text] [Related]

  • 4. Determination of fetal RHD type in plasma of RhD negative pregnant women.
    Sørensen K, Kjeldsen-Kragh J, Husby H, Akkök ÇA.
    Scand J Clin Lab Invest; 2018 Sep; 78(5):411-416. PubMed ID: 29869532
    [Abstract] [Full Text] [Related]

  • 5. [Antenatal determination of fetal RhD-blood type based on fetal DNA in plasma from the RhD-negative mother--secondary publication].
    Clausen FB, Krog GR, Rieneck K, Nielsen LK, Lundquist R, Finning K, Dickmeiss E, Hedegaard M, Dziegiel MH.
    Ugeskr Laeger; 2006 Jun 26; 168(26-32):2568-70. PubMed ID: 16824414
    [Abstract] [Full Text] [Related]

  • 6. Prevalence of RhD status and clinical application of non-invasive prenatal determination of fetal RHD in maternal plasma: a 5 year experience in Cyprus.
    Papasavva T, Martin P, Legler TJ, Liasides M, Anastasiou G, Christofides A, Christodoulou T, Demetriou S, Kerimis P, Kontos C, Leontiades G, Papapetrou D, Patroclos T, Phylaktou M, Zottis N, Karitzie E, Pavlou E, Kountouris P, Veldhuisen B, van der Schoot E, Kleanthous M.
    BMC Res Notes; 2016 Apr 01; 9():198. PubMed ID: 27036548
    [Abstract] [Full Text] [Related]

  • 7. Polymerase-chain-reaction-based detection of fetal rhesus D and Y-chromosome-specific DNA in the whole blood of pregnant women during different trimesters of pregnancy.
    Al-Yatama MK, Mustafa AS, Al-Kandari FM, Khaja N, Zohra K, Monem RA, Abraham S.
    Med Princ Pract; 2007 Apr 01; 16(5):327-32. PubMed ID: 17709918
    [Abstract] [Full Text] [Related]

  • 8. Reliable test for prenatal prediction of fetal RhD type using maternal plasma from RhD negative women.
    Clausen FB, Krog GR, Rieneck K, Nielsen LK, Lundquist R, Finning K, Dickmeiss E, Hedegaard M, Dziegiel MH.
    Prenat Diagn; 2005 Nov 01; 25(11):1040-4. PubMed ID: 16231312
    [Abstract] [Full Text] [Related]

  • 9. Fetal RhD genotyping by real time quantitative PCR in maternal plasma of RhD-negative pregnant women from the Sahel of Tunisia.
    Moussa H, Tsochandaridis M, Jemni-Yacoub S, Hmida S, Khairi H, Gabert J, Levy-Mozziconacci A.
    Ann Biol Clin (Paris); 2012 Nov 01; 70(6):683-8. PubMed ID: 23207814
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Noninvasive fetal RhD status determination in early pregnancy.
    Manzanares S, Entrala C, Sánchez-Gila M, Fernández-Rosado F, Cobo D, Martinez E, Molina L, Reche R, Pineda A, Gallo JL.
    Fetal Diagn Ther; 2014 Nov 01; 35(1):7-12. PubMed ID: 24335165
    [Abstract] [Full Text] [Related]

  • 13. Noninvasive fetal RHD genotyping from maternal plasma. Use of a new developed Free DNA Fetal Kit RhD.
    Rouillac-Le Sciellour C, Sérazin V, Brossard Y, Oudin O, Le Van Kim C, Colin Y, Guidicelli Y, Menu M, Cartron JP.
    Transfus Clin Biol; 2007 Dec 01; 14(6):572-7. PubMed ID: 18375165
    [Abstract] [Full Text] [Related]

  • 14. Use of free fetal DNA in prenatal noninvasive detection of fetal RhD status and fetal gender by molecular analysis of maternal plasma.
    Sedrak M, Hashad D, Adel H, Azzam A, Elbeltagy N.
    Genet Test Mol Biomarkers; 2011 Sep 01; 15(9):627-31. PubMed ID: 21488716
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of non-invasive prenatal RHD genotyping of the fetus.
    Hyland CA, Gardener GJ, Davies H, Ahvenainen M, Flower RL, Irwin D, Morris JM, Ward CM, Hyett JA.
    Med J Aust; 2009 Jul 06; 191(1):21-5. PubMed ID: 19580531
    [Abstract] [Full Text] [Related]

  • 16. [Non invasive fetal RhD genotyping using maternal blood: time for use in all RhD negative pregnant women].
    Carbonne B, Cortey A, Rouillac-Le Sciellour C, Brossard Y.
    Gynecol Obstet Fertil; 2008 Feb 06; 36(2):200-203. PubMed ID: 18243756
    [Abstract] [Full Text] [Related]

  • 17. Fetal RHD genotyping in maternal plasma at 11-13 weeks of gestation.
    Akolekar R, Finning K, Kuppusamy R, Daniels G, Nicolaides KH.
    Fetal Diagn Ther; 2011 Feb 06; 29(4):301-6. PubMed ID: 21212654
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Diagnostic accuracy of non-invasive fetal RhD genotyping using cell-free fetal DNA: a meta analysis.
    Zhu YJ, Zheng YR, Li L, Zhou H, Liao X, Guo JX, Yi P.
    J Matern Fetal Neonatal Med; 2014 Dec 06; 27(18):1839-44. PubMed ID: 24422551
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.